EUPATI is a Consortium of 29 organisations, led by the European Patients’ Forum comprising a combination of pan-European patient organisations, academic and not for profit organisations expert in patient and public engagement and EFPIA member companies.
Project aims: EUPATI 2017 Programme builds on the EUPATI project (February 2012- January 2017), which aimed at providing scientifically reliable, objective, comprehensive information to patients on medicines research and development and to increase the capacities and capabilities of well-informed patients and patient organisations to be effective advocates and advisors in medicines research, e.g. in clinical trials, with regulatory authorities and in ethics.
Project leader: European Patients Forum (EPF)
Main partners: Steering Group includes EPF, Bayer, EATG, ISPOR, Novo-Nordisk, GSK, Eurordis, IPPOSI, Biopeople and EFGCP. The consortium (in development), includes currently about 30 different stakeholders from patient organisations, academia, regulators and industry.
Duration: February 2017 – December 2019
Main funding source/programme: Industry, public partners and EIT in a PPP structure
Budget: Approx 500,000 EUR, 28,900 EUR for EATG
Contact person(s): Giorgio Barbareschi (office) at firstname.lastname@example.org; Maria Dutarte (office) at maria.dutarte@eatg; David Haerry (EATG membership) at email@example.com; Tamás Bereczky (EATG membership) at firstname.lastname@example.org.